First Accurate Recent-Use Cannabis Test Launched by Sensabues and RCU Labs
Sensabues AB (“Sensabues”), a leading provider of breath collection technology for detection of drugs, doping and diseases, today announced that it has partnered with RCU Labs, Inc. (“RCU Labs”), a leader in the development of a dual-matrix test for recent cannabis use.
The partnership will see Sensabues and RCU Labs combine their respective technologies to launch the first accurate Recent Cannabis Use Test (“RCU Test”) using breath collection. The new test solves one of the most scientifically elusive issues of the cannabis industry: how to determine whether an impaired driver or employee is under the influence of cannabis.
The RCU Test is the first reliable test method to accurately determine recent cannabis use within the impairment window. The RCU Test is a practical alternative to zero-tolerance and arbitrary tetrahydrocannabinol (THC) drug level policies.
This collaboration seeks to advance the application breakthrough achieved by the RCU Test for law enforcement, workplace drug testing and anti-doping in sport with regard to ease of use and deployment in the field, as well as analytical accuracy in the lab. The RCU Test has obvious applications for law enforcement (roadside DUI collection), for employers investigating workplace incidents (with cause and post-accident situations) and for anti-doping in sport (in-competition testing of athletes and players).
Under this agreement, both parties will work to offer a full suite of approved RCU all-in-one and one-time-use test kits together with the validated RCU analytical lab services. Further joint development of RCU Labs’ method is planned to extend the offering to include a definitive recent-use test for other drug groups such as stimulants and performance enhancing drugs.
John Trainor, CEO at Sensabues, said: “RCU Labs has made a major breakthrough with their recent-use test, so Sensabues is delighted to partner with such an innovative US laboratory. The increasing worldwide legalization of medicinal and recreational cannabis use has made zero-tolerance and per se limits…